NMRA$0.6021+21.46%
Neumora Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$113.38M
Float & O/S:111.04M / 188.32M
Inst Own:40.4%
DilutionScan read 34 of Neumora Therapeutics, Inc.'s SEC filings and found 2 convertibles, 1 ATM program and 1 shelf registration on file for NMRA. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
